ABSTRACT
Objectives to evaluate the association of sex-and-gender-specific cardiovascular disease risk factors, their prevalence, and correlates among adults in Sierra Leone.
Study design This community-based cross-sectional study used a stratified multistage random sampling.
Methods the survey was conducted in eight (8) selected randomized sub-zonal communities across the western urban area in Sierra Leone, with an included sampling of 2394 adults. The WHO stepwise approach for non-communicable diseases was utilized. Multivariable logistic regression was done to determine associations between demographic characteristics and cardiovascular risk factors.
Results The prevalence of hypertension (33.4% vs 37.4%, p=0.068), diabetes mellitus (7.4% vs 9.2%, p=0.101), overweight (32.3% vs 34.2%, p=0.323) and obesity (9.9% vs 10.2%, p=0.818) were higher among males in comparison to females. Body Mass Index (BMI) (25.0 ± 5.0 vs 24.6 ± 4.4, p = 0.029), waist circumference (WC) (93.6 ± 4.5 vs 80.0 ± 5.0, p < 0.001), triglyceride (1.7±0.35 vs 1.6±0.32, p=0.013), total cholesterol (5.1±0.77 vs 4.9±0.66, p < 0.001) and low HDL-C (1.28 ± 0.29 vs 1.3±0.24, p = 0.016) were significantly higher among females as compared to males. The odds of having dyslipidemia [OR = 1.339; 95% C.I: (1.101-1.629), p=0.003] and consuming alcohol [OR = 1.229; 95% C.I: (1.026-1.472), p=0.025] were higher among females. Women had 1.8 times greater odds [AOR=1.849; 95% C.I: (0.713 - 1.010), p=0.030] of being hypertensive, 1.4 times greater odds [AOR=1.441; 95% C.I: (1.176 - 1.765), p=<0.001] of being dyslipidemic and 1.2 times greater odds [AOR = 1.225, 95% C.I: (1.0123-1.481), p=0.037] of consuming alcohol compared to men. BMI, WC, and raised blood sugar had a strong correlation among women than men.
Conclusion Being female was associated with a high prevalence of cardiovascular health risks in Sierra Leone. This study emphasizes the importance of reducing the CVD burden among females through policies related to public health education and screening strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Ecobank Limited Sierra Leone
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Sierra Leone Ethics and Scientific Review Committee approved the research protocol, questionnaire, and consent form.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
trkoroma90{at}gmail.com
sanniesay{at}gmail.com
ssallieu{at}yahoo.com
lakoh2009{at}gmail.com
abockarie{at}ucc.edu.gh
berylonome{at}gmail.com
samjokanu{at}yahoo.com
joshuacoker001{at}yahoo.com
abdulpjalloh{at}yahoo.co.uk
vicyandi{at}gmail.com
bigbrosocont{at}gmail.com
mohamed85smith{at}gmail.com
zenu2{at}btinternet.com
durodamil{at}yahoo.co.uk
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- BMI
- Body Mass Index
- CMD
- Cardiometabolic Disease
- CMRF
- Cardiometabolic risk factors
- CVD
- cardiovascular disease
- CVDRF
- cardiovascular disease risk factors
- DBP
- diastolic blood pressure
- LDL-C
- Low-density lipoprotein cholesterol
- LMIC
- low-and middle-income countries
- LVH
- left ventricular hypertrophy
- LVMI
- Left ventricular mass index
- NCD
- Non-communicable disease
- HDL-C
- High-density lipoprotein cholesterol
- SSA
- Sub-Sahara African
- SBP
- systolic blood pressure
- SLE
- Leones currency
- TG
- triglyceride
- TOD
- target organ damage
- WC
- waist circumference
- WHO
- World Health Organization
